Curis reported $-8800000 in EBIT for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Amgen AMGN:US $ 2129M 121M
AstraZeneca AZN:LN 1.03B 425M
Bayer BAYN:GR 3.07B 885M
Bristol Myers Squibb BMY:US $ 2556M 1406M
Chimerix CMRX:US -14563000 2.81M
Curis CRIS:US $ -8800000 2.52M
Eli Lilly And LLY:US $ 1666.2M 662.1M
Gilead Sciences GILD:US $ 2912M 261M
GlaxoSmithKline GSK:LN 1.68B 59M
Merk MRK:US $ 4290M 4007M
Mirati Therapeutics MRTX:US $ -132421000 26.09M
Novartis NOVN:VX 2.99B 332M
Pfizer PFE:US $ 5757M 4605M
Tg Therapeutics TGTX:US $ -89202000 2.42M
Verastem VSTM:US $ -14108000 2.81M
Xoma XOMA:US $ -6427000 30.3M
YTE INCY:US $ 114.81M 65.45M
Ziopharm Oncology ZIOP:US $ -21563000 1.21M